摘要
应激性溃疡(Stress Ulcer,SU)又称急性胃黏膜病变,指机体受各种外源性或内源性致病因素刺激(创伤、脑血管意外、精神心理异常),产生黏膜血流减少[1]、黏膜防御机制破坏、胃酸和胃蛋白酶分泌增加等病理生理改变,
出处
《湖北医药学院学报》
CAS
2012年第3期242-244,共3页
Journal of Hubei University of Medicine
参考文献15
-
1Allen ME,Kopp B J,Erstad BL. Stress ulcer prophylaxis in the postoperative period[J].American Journal of Health-System Pharmacy,2004,(06):588-596.
-
2Spirt MJ. Stress-related mucosal disease:risk factors and prophylactic therapy[J].Clinical Therapeutics,2004,(02):197-213.doi:10.1016/S0149-2918(04)90019-7.
-
3Itoh H,Naito T,Takeyama M. Lafutidine changes levels of somatostatin,calcitonin gene-related peptide,and secretin in human plasma[J].Biological and Pharmaceutical Bulletin,2002,(03):379-382.
-
4Svoboda P,Kantorova I,Scheer P. Helicobacter pylori is not a risk factor for stress ulcer bleeding in polytraumatized patients[J].Hepato-Gastroenterology,2004,(56):476-480.
-
5Akiba Y,Kaunitz JD. Lafutidine,a protective H2 receptor antagonist,enhances mucosal defense in rat esophagus[J].Digestive Diseases and Sciences,2010,(11):3063-3069.
-
6Ikawa K,Shimatani T,Azuma Y. Calcitonin gene-related peptide and somatostatin releases correlated with the area under the lafutidine concentration-time curve in human plasma[J].Journal of Clinical Pharmacy and therapeutics,2006,(04):351-356.doi:10.1111/j.1365-2710.2006.00749.x.
-
7Pilkington KB,Wagstaff M J,Greenwood JE. Prevention of gastrointestinal bleeding due to stress ulceration:a review of current literature[J].Anaesthesia and Intensive Care,2012,(02):253-259.
-
8Tarnawski A,Stachura J,Krause WJ. Quality of gastric ulcer healing:a new,emerging concept[J].Journal of Clinical Gastroenterology,1991,(Suppl 1):S42-S47.
-
9Preiser JC. Ranitidine and gastrointestinal bleeding in intensive care.Should prophylaxis against stress ulcer be abondoned for patients in intensive care[J].British Medical Journal,2001,(7 292):995.
-
10Faisy C,Guerot E,Diehl JL. Clinically significant gastrointestinal bleeding in critically ill patients with and without stress-ulcer prophylaxis[J].Intensive Care Medicine,2003,(08):1306-1313.doi:10.1007/s00134-003-1863-3.
同被引文献60
-
1李兆申.重视应激性溃疡的规范化防治[J].世界华人消化杂志,2005,13(22):2637-2639. 被引量:88
-
2赵海英,梁晓梅,张澍田,于中麟,袁耀宗,侯晓华,刘吉勇,王炳元.拉呋替丁片治疗十二指肠溃疡的多中心、随机、双盲、双模拟对照研究[J].临床内科杂志,2007,24(4):250-252. 被引量:9
-
3许桦林.消化性溃疡愈合质量的影响因素及其对策[J].医药导报,2007,26(10):1232-1234. 被引量:21
-
4李成龙,屠伟峰.辣椒素-敏感感觉神经在胃黏膜细胞保护中的作用[J].实用医学杂志,2007,23(22):3633-3635. 被引量:2
-
5Kudo T,Fujinami H,Ando T. Comparison of lafutidine and rabeprazole in 7-day second-line amoxicillin-and metronidazolecontaining triple therapy for Helicobacter pylori:a pilot study[J].Helicobacter,2012,(04):277-281.
-
6Nagano H,Sanai H,Muraoka M. Efficacy of lafutidine,a histamine H2-receptor antagonist,for taxane-induced peripheral neuropathy in patients with gynecological malignancie[J].Gynecologic Oncology,2012,(01):172-174.
-
7Iida H,Inamori M,Uchiyama T. Early effects of oral administration of lafutidine with peppermintoil,compared with lafutidine alone,on intragastric pH values[J].Hepato-Gastroenterology,2011,(105):235-238.
-
8Kawaguchi K,Ishiguro H,Morita S. Correlation between docetaxel-induced skin toxicity and the use of steroids and Hblockers:a multi-institution survey[J].Breast Cancer Research and Treatment,2011,(02):627-634.
-
9Kato M,Kamada G,Yamamoto K. Lafutidine prevents low-dose aspirin and loxoprofen induced gastric injury:a randomized,doubleblinded,placebo controlled study[J].Journal of Gastroenterology and Hepatology,2010,(10):1631-1635.
-
10Ohara S,Haruma K,Kinoshita Y. A double-blind,controlled study comparing lafutidine with placebo and famotidine in Japanese patients with mild reflux esophagitis[J].Journal of Gastroenterology,2010,(12):1219-1227.
引证文献6
-
1黄更珍,贺国斌,张耀丹,明文,左锦,张琴.拉呋替丁联合康复新液及心理干预治疗应激性溃疡的疗效[J].南昌大学学报(医学版),2013,53(6):68-69. 被引量:3
-
2王贺,崔颖,李姜晖,周国勤,刘羽,孙备.拉呋替丁片的处方工艺及稳定性研究[J].中国医药导报,2013,10(25):104-106. 被引量:3
-
3金玉,曾繁典,谭诗云.具抑酸和消化道黏膜保护作用的H_2受体拮抗药拉呋替丁[J].医药导报,2014,33(7):891-894. 被引量:11
-
4周增娜.分析拉呋替丁胶囊治疗胃溃疡患者的有效性与安全性[J].中国中西医结合消化杂志,2016,24(5):397-399. 被引量:2
-
5张翠霞,郭丽芳,尚琪,温萌,张德奎.拉呋替丁的临床研究进展[J].医学综述,2017,23(16):3275-3280.
-
6崔志鹏.海贝建中组方治疗神经源性应激性溃疡的效果观察[J].中国妇幼健康研究,2017,28(S2):170-170.
二级引证文献16
-
1徐治群,李秀梅.神经末梢受体在胃食管反流病中的作用[J].中国实用神经疾病杂志,2016,19(4):5-8. 被引量:2
-
2金玉,谭诗云,张家明.质子泵抑制药和H_2受体阻断药对氯吡格雷抗血小板作用的影响[J].医药导报,2016,35(5):501-504. 被引量:11
-
3周增娜.分析拉呋替丁胶囊治疗胃溃疡患者的有效性与安全性[J].中国中西医结合消化杂志,2016,24(5):397-399. 被引量:2
-
4边竞,孙明立,于兆进,陈文捷,何林秀,李亚楠,魏敏杰.ω-6大豆油脂肪乳对大鼠实验性胃溃疡的保护作用[J].医药导报,2016,35(7):698-701.
-
5钟天胜.大剂量奥美拉唑防治应激消化道黏膜损伤的研究[J].北方药学,2016,13(8):62-63. 被引量:1
-
6刘晓伟,曾繁典,谭诗云.质子泵抑制药与组胺H_2受体阻断药联合防治夜酸突破进展[J].医药导报,2016,35(11):1208-1211. 被引量:5
-
7王文勇.拉呋替丁治疗非甾体类抗炎药致胃黏膜损伤临床观察[J].基层医学论坛,2017,21(1):48-49. 被引量:1
-
8丁锦希,刘莹芳,姚雪芳,李伟,董锐,高雪.一致性评价对药品集中采购竞价分组的影响机制分析[J].中国医药工业杂志,2017,48(4):605-613. 被引量:6
-
9张翠霞,郭丽芳,尚琪,温萌,张德奎.拉呋替丁的临床研究进展[J].医学综述,2017,23(16):3275-3280.
-
10陈怡.拉呋替丁胶囊治疗胃溃疡患者的有效性与安全性探讨[J].华夏医学,2018,31(4):72-75. 被引量:1
-
1韦海潮.雷贝拉唑钠治疗胃食管反流病150例临床研究[J].中国临床医生杂志,2015,43(4):58-60. 被引量:4
-
2翟力平,安贺娟,盛剑秋.拉呋替丁治疗消化性溃疡疗效及安全性观察[J].中国医药导刊,2015,17(8):805-806. 被引量:4
-
3赵海英,梁晓梅,张澍田,于中麟,袁耀宗,侯晓华,刘吉勇,王炳元.拉呋替丁片治疗十二指肠溃疡的多中心、随机、双盲、双模拟对照研究[J].临床内科杂志,2007,24(4):250-252. 被引量:9
-
4黄更珍,贺国斌,张耀丹,明文,左锦,张琴.拉呋替丁联合康复新液及心理干预治疗应激性溃疡的疗效[J].南昌大学学报(医学版),2013,53(6):68-69. 被引量:3
-
5尤海墩,翁礼端,张衡仁.应激性溃疡18例临床诊治分析[J].中国民族民间医药,2012,21(5):84-84. 被引量:1
-
6马风华,侯永辉.急性脑血管病应激性溃疡58例护理干预[J].河北中医,2010,32(5):765-766. 被引量:1
-
7李延召.拉呋替丁与兰索拉唑治疗消化性溃疡临床对比分析[J].临床医学研究与实践,2016,1(13):91-91. 被引量:6
-
8王卫卫.拉呋替丁与兰索拉唑治疗胃溃疡的对照研究[J].中华全科医学,2014,12(8):1344-1345. 被引量:13
-
9拉呋替丁[J].中国医药技术与市场,2004,4(3):40-41.
-
10周增娜.分析拉呋替丁胶囊治疗胃溃疡患者的有效性与安全性[J].中国中西医结合消化杂志,2016,24(5):397-399. 被引量:2